
How weight-loss drugs are impacting Indian women with PCOS and infertility
With the launch of Wegovy, a globally recognised weight-loss drug, and Mounjaro, earlier launched by US medicine company Eli Lilly, India has entered a new phase in the management of obesity.For years, doctors and patients alike have grappled with the challenge of tackling obesity, especially in women. Now, with newer tools at hand, experts believe the tide may finally be turning.advertisementRenowned gynaecologist Dr. Rishma Pai speaks at length about how obesity is no longer just a cosmetic issue, it is a medical condition with deep consequences, especially for women dealing with PCOS (Polycystic Ovary Syndrome), infertility, and post-menopausal health risks.
According to Dr. Pai, nearly one in three women in India is living with obesity. 'Obesity is not just about appearance, it's ABCD: adiposity-based chronic disease,' she says.This includes a wide range of health issues like diabetes, high blood pressure, infertility, sleep apnea, arthritis, and even some cancers of the breast and uterus.For women, the burden is heavy because obesity affects them differently, and often more severely, than men.
With newer tools at hand like new-age drugs, experts believe the tide may finally be turning for obesity. ()
advertisementFrom adolescence to menopause, hormonal changes make it harder to lose weight, and easier to gain it.PCOS AND THE WEIGHT STRUGGLEPCOS affects 30–35% of young women in India and is closely linked to obesity. Dr. Pai, a consulting gynaecologist at Lilavati Hospital, PD Hinduja Hospital, Sir HN Reliance Foundation Hospital, says she sees many women battling irregular periods, acne, facial hair, and weight gain -- all classic signs of PCOS.'The sad part is that until now, we had very little to offer these young women. The older weight-loss medicines barely helped them lose 2–3 kg. It was frustrating for both doctors and patients,' she tells IndiaToday.in.However, even a 5% weight loss can significantly improve symptoms.'Once these women lose just a bit of weight, periods become regular, ovulation gets better, and in many cases, fertility improves, without the need for any other medication," she adds.
PCOS affects 30–35% of young women in India and is closely linked to obesity. ()
Dr. Pai sees this as a major step forward in pre-pregnancy care. 'Many women walk into my clinic weighing 85 kg and planning a pregnancy. If they become pregnant at this weight, they often cross 100 kg during pregnancy. This puts them at high risk for diabetes, hypertension, and complications. Doctors too are stressed managing these high-risk pregnancies.'advertisementShe recommends a focused pre-pregnancy weight-loss plan, ideally stopping the medication a month before trying to conceive.THE MENOPAUSE METABOLIC SHIFTMenopause presents another weight-related hurdle. 'Even women who've been slim their whole lives suddenly find their midsections expanding,' she says. This midlife weight gain is driven by hormonal shifts and puts women at increased risk for heart disease, metabolic disorders, and certain cancers.Dr. Pai stresses that women at every life stage, from puberty to menopause, must be supported in achieving a healthy body weight.BEYOND THE SCALE: SHAME, STIGMA AND MENTAL HEALTHDr. Pai calls to treat obesity with compassion, as even healthcare professionals can be biased. "When an overweight woman walks into a clinic, many assume she's lazy or careless. That's simply not true,' she says.The problem is worsened by the pressure women face to look a certain way, especially in the age of social media. 'Pre-wedding weight loss has become almost compulsory. Brides starve themselves or opt for surgeries, just to look good in photos. But after the wedding, many regain all the weight,' she adds.
A focused pre-pregnancy weight-loss plan, ideally stopping the medication a month before trying to conceive. ()
advertisementA 2022 Novo survey conducted across Asia-Pacific found that one-third of people with obesity refused to acknowledge their condition. Two-thirds blamed themselves for it. 'This shows how little we understand obesity as a chronic disease,' said Dr. Pai.WEIGHT-LOSS DRUGS: NOT A MAGIC CURE, BUT A POWERFUL TOOLDr. Pai believes drugs like semaglutide (Wegovy) are not miracle cures, but they can be powerful allies.She insists that the use of these drugs must be part of a bigger, long-term strategy that includes counselling, behavioural change, and consistent follow-up.Weight-loss drugs can be added to pre-pregnancy programs as well, to help women lose weight, become healthier, and then stop the medication one month prior to planning pregnancy. But this needs to be done very strategically, under medical supervision with a sustainable lifestyle.advertisement'You can't take these medicines for six months, then binge-eat and expect to maintain weight loss. Sustaining it is even harder than achieving it," she says.Still, the results are motivating. 'When a woman sees even a few kgs drop, she feels confident and inspired. That's the start of a bigger transformation.'More than anything, Dr. Pai wants to change how we talk about weight: 'Let's stop saying thin equals healthy. Fitness is not just about looks. There are thin women with high body fat and low muscle mass. We need to create awareness—not judgement.'- EndsMust Watch
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Indian Express
an hour ago
- Indian Express
How novel weight loss drugs help 40-year-old lose 16 kg over a year: First she was on semaglutide pill, then Mounjaro shots
For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and has more energy to ride out her 10 am to 7 pm work days and the pressure of deadlines. Tired of seeing the weighing scale needle tipping over the 90 kg mark and her blood sugar levels spiral despite fad diets, gym routines and natural supplements, she is now 74 kg. For the past year, she had been on the oral weight loss drug semaglutide (Rybelsus) but since she couldn't tolerate its side effects well, has had better results with tirzepatide (Mounjaro) this year. 'I needed that one push to get off the weight plateau, steel my mind and focus on getting better and be disease-free. Mounjaro accelerated the process,' says Bindra, who has battled uncontrolled diabetes, PCOS (polycystic ovary syndrome), hypothyroidism and fatty liver because of her weight. Her appetite has now gone down by 30-40 per cent, her binge cravings are zero and she has managed to tame the 'food noise' that made her peckish through the day. Food was not just her pleasure but escapism, something that Dr Jasjeet Singh Wasir, her endocrinologist and diabetologist at Medanta, understood when she consulted him last year. That's why he put her on a new class of weight loss drugs. Her blood sugar readings are better and her HbA1c (average blood sugar count of three months) has gone down from 8 per cent to 7.3 per cent (normal is less than 5.6 per cent). The new drugs are more than a life-saver for people like Bindra as they help them eliminate several obesity-related risk factors. The GLP-1 receptor agonists mimic natural gut hormones responsible for blood sugar and appetite control, such as semaglutide – the active ingredient in Wegovy. It improves secretion of insulin, inhibits glucose production in the liver and slows down digestion. Tirzepatide, sold as Mounjaro, additionally mimics the GIP hormone, primarily by stimulating insulin release from the pancreas. GIP also influences lipid metabolism. THE INSIDIOUS WEIGHT GAIN Bindra never realised how a sedentary lifestyle, long work hours, performance anxiety and stress-eating had turned into belly fat. Then she gained weight all over. After developing Covid in 2020 and 2022, her random blood tests showed a blood glucose level of 190 mg/dL and a HbA1c count of 5.8 per cent. In April 2023, during her executive health check-up, she was diagnosed with type 2 diabetes as her HbA1c shot up to 8.4 per cent. Looking at her body weight, family history of diabetes and her dual role as professional and caregiver for her parents, Dr Wasir put her on oral semaglutide or Rybelsus pills, mainly to control her diabetes though it also helps in some weight loss. According to randomised controlled trials, one starts losing weight immediately after taking Rybelsus. After one month, the average weight loss on Rybelsus is around 2 kg; after two months, it's over 3 kg. THE SIDE EFFECTS OF A PILL 'I constantly had nausea, vomitting, diarrhoea, fatigue, constipation and headaches. My body simply did not take to semaglutide,' says Bindra. Then Dr Wasir put her on the injectable tirzepatide. 'Around 300 patients of mine on weight loss pills had extreme gastric symptoms. The same patients are tolerating the injectable Mounjaro better,' he says. Since Mounjaro mimics two hormones involved in appetite regulation and glucose control, this dual action may result in more significant weight loss and potentially better blood sugar control. This can indirectly improve overall tolerability. However, Dr Wasir attributes tolerability to the grading of doses. Most of his patients begin from 2.5 or 5 mg, which is a kind of stage one and stage two doses. Then it goes up to 7.5 mg and a maximum dose of 15 mg. 'It's still very early for us to arrive at an observation,' he says. BEGINNING WITH MOUNJARO Bindra started with a low 1.25 mg dose. Once she could tolerate it, Dr Wasir upgraded the dose to 2.5 mg. But at the same time, he insisted she make lifestyle changes, particularly her diet and exercise. 'I cut down on junk food, fried items and oily meals. I used to binge-eat when I was stressed and that's significantly reduced now. I am into plant proteins,' she adds. Now Bindra focusses on simple, home-cooked foods that keep her stomach happy. 'Looking back, that kick we seek in our food rather than exercising was the reason I always craved the spicier and heavier chole bhature or rajma rice. This dietary shift has influenced some of my health markers, too,' she says. Mounjaro has been an effective appetite suppressant. 'I used to eat two rotis but now I'm comfortable with one. I can portion-control. Interestingly, I no longer feel as hungry as before or feel dizzy. I have given up alcohol too, though I was nothing beyond a social drinker,' says Bindra. WATCH OUT FOR MUSCLE LOSS AFTER USING MOUNJARO For Dr Wasir, the key challenge remains her protein intake, now that she only has plant proteins. 'There's always a risk of muscle loss alongside fat loss, which can be hard to reverse. We're working on optimizing her protein intake to support muscle health during weight loss,' he adds. On her part, Bindra never misses her strength training sessions. 'I repeat it at every visit — your investment in muscle is as important as your medication,' says Dr Wasir. DO THE DRUGS NEED TO BE TAKEN INDEFINITELY? Dr Wasir says clinical trials for both semaglutide and tirzepatide have lasted between 72 and 88 weeks. But they don't provide a clear answer on how long treatment should continue. Trials show taking off the drug midway leads to weight regain. 'Based on current evidence, these medications appear to be intended for long-term use. As for long-term efficacy, we rely on two things: the duration of clinical trials and real-world experience after approval. For example, even if a drug was trialled for two years, if it has been used safely for five years since, we consider that seven years of practical experience,' he adds.
&w=3840&q=100)

Business Standard
3 hours ago
- Business Standard
Fact-Check: Are These Instagram Fitness Fads Backed by Science?
From moon-charged water to 100 Surya Namaskars a day—your Instagram feed is bursting with fitness trends. But do they actually work? Or are we sipping on pseudoscience? Welcome to Fact-check Friday, where we decode viral fitness claims with real doctors and experts. ACV has a fan club on social media—claimed to balance hormones and torch fat. But experts say: not quite. It may slow sugar spikes and help PCOS a little, but it's no miracle elixir.


India Today
13 hours ago
- India Today
Do weight-loss drugs really lead to muscle loss?
Do weight-loss drugs really lead to muscle loss? Credit: Getty Images Renowned endocrinologist and diabetologist Dr Ambrish Mithal told talked about muscle loss after consuming popular weight-loss drugs. While reducing weight, whether one is on a diet or even with exercise, body fat along with muscle tends to reduce. Muscle loss 'The body isn't so fine tuned to reduce fat only during weight loss. When you lose weight, you lose both fat and some muscle. To limit that, you need strength training and enough protein,' he explained. Exercise, especially strength training, is important to prevent muscle loss, a natural part of rapid weight loss, whether it's achieved through medication, dieting, or surgery. With both Wegovy and Mounjaro now accessible, India finally has two cutting-edge medical options in the fight against obesity. 'These drugs are designed for long-term use. They're filling a big gap in obesity care. But that doesn't mean lifestyle takes a back seat. These drugs work with lifestyle, not instead of it," said Dr. Mithal. Weight-loss drugs do not replace diet The current guidelines suggest prescribing drugs like semaglutide or tirzepatide to people with a BMI over 30, or between 27 and 30 if they have conditions like diabetes, high blood pressure, or heart disease. Guidelines for prescribing While Wegovy was launched on June 24, Mounjaro as available in the Indian market since March 2025. Expert have said that the new-age weight-loss drugs are not a magic cure but powerful ally to reducing obesity crisis.